{
    "code": "02018922",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02018922",
    "time": "2016-11-18 19:34:40",
    "許可證字號": "衛署藥輸字第018922號",
    "註銷狀態": "已註銷",
    "註銷日期": "88\/08\/30",
    "註銷理由": "未依公告執行ＢＡ？ＢＥ試",
    "有效日期": "90\/11\/26",
    "發證日期": "80\/11\/26",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201892207",
    "中文品名": "理邁黴素３００公絲膠囊",
    "英文品名": "RIMYCIN 300MG CAPSULES",
    "適應症": "結核病、麻瘋、預防可能因接觸腦膜炎患者及帶原者而引起之腦膜炎。接觸感染Ｂ型流行性感冒。",
    "劑型": "130膠囊劑",
    "包裝": "瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "RIFAMPIN(EQTORIFAMPICIN)(EQTORIMACTAN)"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1223901100  華特實業股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F020003000  ALPHAPHARM PTY LTD.",
        "製造廠廠址": "CNR GARNET &amp; ANTIMONY STREET, CAROLE PARK, QLD 4300 AUSTRALIA12 CROWN STREET, GLEBE NSW 2037 AUSTRALIA",
        "製造廠公司地址": "12 CROWN STREET, GLEBE NSW 2037 AUSTRALIA",
        "": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812900100",
            "成分名稱": "RIFAMPIN (EQ TO RIFAMPICIN) (EQ TO RIMACTAN)",
            "含量描述": "300",
            "含量": "300.0000000000",
            "單位": "MG"
        }
    ]
}